We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Urine Analyzer Evaluated for Performance

By LabMedica International staff writers
Posted on 02 Oct 2017
Urinalysis is one of the most commonly requested laboratory tests, the third after the biochemical profile and the blood cell count, and it is very useful to screen for diseases of the kidney and urinary tract.

Microscopic evaluation of the sediment particles is a time consuming procedure, with high imprecision and inaccuracy; furthermore, it requires expert knowledge and it is strongly influenced by the inter-observer variability. More...
In recent years, automation of urinary sediment has overcome these limits.

Clinical chemists at the Papa Giovanni XXIII Hospital (Bergamo, Italy) selected 736 fresh, first morning, clean catch mid-stream urine samples from the samples sent to the Clinical Chemistry Laboratory during the period May–October 2016. Samples were selected in order to cover all the linearity range for all the parameters where possible; analyses concentrations were distributed over the analytical measurement range of the urine analyzer.

Each sample was sequentially analyzed on the Aution Max AX-4280 automated urine test strip analyzer and the Sysmex UF-1000i. The new analyzer evaluated was the Sysmex UF-5000 which is able to recognize, count and classify cells by analyzing forward scatter light (FSC), side scatter light (SSL), side fluorescent light (SFL) and depolarized side scattered light (DSS). DSS was introduced to improve the sensitivity of crystals and to better discriminate the red blood cells and crystals. For the comparative method, Fuchs-Rosenthal chamber (FRC) counting with a phase contrast microscope using an eyepiece set at ×10and a lens set at ×40, for a total of ×400, was used as a reference manual method.

The scientists reported that the AUC of ROC curve ranged between 0.86 and 0.99. Sensitivity was greater than 90% for all the elements and similar for red blood cells (RBC) and yeasts. Specificity ranged between 74% and 89% for total cast, epithelial/non-squamous/renal-tubular cells and RBC. For all the other parameters specificity was greater than 90%. Comparison with Fuchs- Rosenthal chamber was very good for all the parameters except for pathological cast because of the lack of the pathological samples in medium and higher ranges.

The authors concluded that their study assessed the newly introduced UF-5000 which they found is a really simple, useful and accurate analyzer to detect urine particles related to the pathological process of kidney and urinary tract. All the parameters showed a high negative predictive value (NPV), so it is possible to exclude the presence of a disease with a great probability when a urine sample is negative.

On the other hand, the robust statistical analysis observed for all the parameters, especially those with an important clinical impact and higher than the ones obtained by image-based analyzers, makes UF-5000 an analyzer of great interest, recommended in routine practice, also for complex case mix laboratory. The study was published in the September 2017 issue of the journal Clinica Chimica Acta.

Related Links:
Papa Giovanni XXIII Hospital


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: The model combines digitized tumor histopathology, clinical variables, and a 42-gene molecular panel using AI to generate a unified recurrence risk prediction (Image Credit: Shutterstock)

Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

Predicting which patients with early-stage breast cancer will develop distant recurrence remains difficult, complicating decisions about long-term therapy and surveillance. Widely used genomic assays are... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.